Spectral AI (NASDAQ:MDAI) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Key Points

• Spectral AI beat earnings expectations, reporting a quarterly loss of $0.13 per share versus the $0.14 consensus estimate. Revenue of $3.52 million fell short of analysts’ $4.17 million forecast.
• The company received FDA De Novo clearance for its DeepView burn-assessment system and plans a phased commercial rollout of up to 30 U.S. installations through June 2027, supported by BARDA funding.
• Spectral AI reiterated full-year revenue guidance of approximately $18.5 million, while reporting $14 million in cash and access to more than $60 million in additional non-dilutive BARDA funding to support its launch.

Spectral AI (NASDAQ:MDAI - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.01, FiscalAI reports. The business had revenue of $3.52 million for the quarter, compared to analyst estimates of $4.17 million.

Here are the key takeaways from Spectral AI's conference call:

• Positive Sentiment: Spectral AI received FDA De Novo clearance for its DeepView burn-assessment system, validating the technology and enabling its transition from development to commercialization.
• Positive Sentiment: The company plans a staged launch targeting up to 30 U.S. installations through June 2027, supported by BARDA funding, while pursuing updated UKCA clearance in the fourth quarter and initial international placements.
• Neutral Sentiment: Second-quarter R&D revenue fell to $3.5 million from $5.1 million year over year as major studies were completed and BARDA work shifted to a cost-sharing phase; full-year revenue guidance was reiterated at approximately $18.5 million and excludes significant DeepView sales.
• Positive Sentiment: Spectral AI reported $14 million in cash, access to more than $60 million of additional non-dilutive BARDA funding, and no principal payments on its debt through March 2027, providing resources to fund the commercial launch.
• Neutral Sentiment: Deployment may be slowed by hospital procurement, cybersecurity, and AI-committee reviews, while the company expects to begin a 12-center U.S. triage and treatment-outcome study in the fourth quarter of 2026.

Spectral AI Price Performance

MDAI stock remained flat at $1.71 on Tuesday. The company had a trading volume of 211,916 shares, compared to its average volume of 566,869. Spectral AI has a 1-year low of $1.18 and a 1-year high of $2.97. The company has a market capitalization of $54.41 million, a P/E ratio of -3.23 and a beta of 1.18. The business has a 50 day simple moving average of $1.73 and a two-hundred day simple moving average of $1.75.

Analysts Set New Price Targets

MDAI has been the subject of a number of recent research reports. Northland Securities upgraded Spectral AI to a "strong-buy" rating in a research note on Monday, July 27th. BTIG Research boosted their price target on shares of Spectral AI from $3.00 to $4.00 and gave the company a "buy" rating in a report on Tuesday, May 26th. Finally, Weiss Ratings upgraded shares of Spectral AI from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Monday, June 29th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $4.00.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. grew its stake in shares of Spectral AI by 1,180.0% in the third quarter. Raymond James Financial Inc. now owns 12,800 shares of the company's stock worth $29,000 after purchasing an additional 11,800 shares in the last quarter. Jane Street Group LLC bought a new stake in shares of Spectral AI during the second quarter valued at about $74,000. Marshall Wace LLP acquired a new stake in Spectral AI in the second quarter worth about $104,000. XTX Topco Ltd bought a new position in Spectral AI in the 2nd quarter valued at about $123,000. Finally, Virtu Financial LLC acquired a new position in Spectral AI during the 4th quarter valued at about $75,000. Institutional investors and hedge funds own 67.08% of the company's stock.

About Spectral AI

Spectral AI, Inc NASDAQ: MDAI is a technology company focused on delivering advanced analytics and insights through the application of machine learning to multi-spectral and hyperspectral data. Its core platform ingests imagery from satellites, aerial drones and ground-based sensors, applying proprietary algorithms to identify patterns and anomalies invisible to the naked eye. The company's solutions are designed to help clients make more informed decisions in areas such as agriculture, environmental monitoring, infrastructure inspection and resource exploration.

The company offers a cloud-native software-as-a-service (SaaS) platform that enables users to visualize and analyze large volumes of spectral data via customizable dashboards.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source